<rows>
  <row id="1130626" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>Primary central nervous system (CNS) tumors begin in the brain or spinal cord. About 79,000 people are diagnosed a year with a primary CNS tumor and about 24,000 are malignant. View <a href="https://seer.cancer.gov/statfacts/html/brain.html" target="_blank" rel="noopener noreferrer">Cancer Stat Facts: Brain and Other Nervous System Cancer</a> to see the number of new cases, lifetime risk, and people living with CNS cancers in the United States. All primary CNS cancers are rare, so often disease information, support, and expert care is hard to find.</p>
<p>Learn about CNS tumor anatomy, causes, symptoms, diagnosis, treatments, and who they affect to help you better understand your cancer so you can feel confident in your care.&nbsp;</p>
</div>]]></body>
  </row>
  <row id="1130689" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>Living with a rare brain or spine tumor can impact all aspects of your life. Physical or thinking and memory changes can be caused by the tumor, removal of the tumor, or treatment and can affect your quality of life. This can be challenging for you and your loved ones. And in each stage of your cancer journey, you will face unique challenges. View questions to ask your healthcare team, ways to cope, and treatment and support resources. Hear from patients and caregivers living with rare central nervous system (CNS) tumors to guide you through your journey.</p>
</div>]]></body>
  </row>
  <row id="1133421" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>NCI-CONNECT wants to connect patients, providers, researchers, and community organizations to work in partnership to improve outcomes for adult patients with rare central nervous system (CNS) tumors.</p>
<p>Learn how you can participate in <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1120595" sys_contentid="1120595" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7108928" sys_folderid="" sys_siteid="305" rxinlineslot="103" sys_dependentid="1120595" sys_dependentvariantid="2297">NCI-CONNECT</a>.</p>
</div>]]></body>
  </row>
  <row id="1140626" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<div sys_relationshipid="7371496" sys_dependentid="1123354" rxinlineslot="105" contenteditable="false" sys_dependentvariantid="2489" rxselectedtext="" rxanchortext="" unselectable="on" inlinetype="rxvariant" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list"><ul><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=16&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120631&amp;sys_siteid=305&amp;sys_contentid=1120669&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120669">Atypical Teratoid  Rhabdoid Tumor (ATRT)</a><!-- start description -->
<div class="description"><p class="body">ATRTs are very rare, fast-growing tumors that often occur in the brain and spread to the spinal cord. They are caused by changes in a gene known as SMRCB1. Learn more about ATRTs.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=5&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120635&amp;sys_siteid=305&amp;sys_contentid=1120674&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120674">Choroid Plexus Tumors</a><!-- start description -->
<div class="description"><p class="body">Choroid plexus tumors can be slow- or fast-growing tumors. They arise from a structure in the brain called the choroid plexus. Learn more about choroid plexus tumors.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1121580&amp;sys_siteid=305&amp;sys_contentid=1121585&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1121585">Diffuse Midline Gliomas</a><!-- start description -->
<div class="description"><p class="body">Diffuse midline gliomas are fast-growing tumors. They form in the brainstem, thalamus, spinal cord, and cerebellum. Learn more about brainstem and diffuse midline gliomas.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=12&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120637&amp;sys_siteid=305&amp;sys_contentid=1120675&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120675">Ependymoma</a><!-- start description -->
<div class="description"><p class="body">Ependymoma tumors are more common in the spine than the brain in adults. They often occur near the central canal of the spinal cord and ventricles of the brain. Learn more about ependymomas.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=8&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120639&amp;sys_siteid=305&amp;sys_contentid=1120676&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120676">Gliomatosis Cerebri</a><!-- start description -->
<div class="description"><p class="body">Gliomatosis cerebri tumors arise from glial cells in the brain. They often come back after treatment and are fast-growing. Learn more about gliomatis cerebri tumors.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1121582&amp;sys_siteid=305&amp;sys_contentid=1121584&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1121584">Gliosarcoma</a><!-- start description -->
<div class="description"><p class="body">Gliosarcoma tumors are fast-growing tumors. They are commonly found along the surface of the brain from glial cells. Learn more about gliosarcoma tumors.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=7&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120641&amp;sys_siteid=305&amp;sys_contentid=1120677&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120677">Medulloblastoma</a><!-- start description -->
<div class="description"><p class="body">Medulloblastoma tumors are fast-growing tumors. They commonly form in the cerebellum. Learn more about medulloblastomas.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120643&amp;sys_siteid=305&amp;sys_contentid=1120678&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120678">Meningioma</a><!-- start description -->
<div class="description"><p class="body">Meningioma tumors are the most common type of primary brain tumor, but higher grade meningiomas are very rare, fast-growing tumors. Learn more about atypical and anaplastic meningiomas.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=11&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120645&amp;sys_siteid=305&amp;sys_contentid=1120679&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120679">Oligodendroglioma</a><!-- start description -->
<div class="description"><p class="body">Oligodendroglioma tumors can be slow- or fast-growing tumors. They occur most often in people between the ages of 35 and 44. Learn more about oligodendrogliomas and anaplastic oligodendrogliomas.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=7&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120655&amp;sys_siteid=305&amp;sys_contentid=1120680&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120680">Pineal Region Tumors</a><!-- start description -->
<div class="description"><p class="body">Pineal region tumors occur in the middle of the brain in the pineal region. They can spread to other areas in the central nervous system. Learn more about pineal region tumors.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=10&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120649&amp;sys_siteid=305&amp;sys_contentid=1120681&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120681">Pleomorphic Xanthoastrocytoma (PXA) and Anaplastic Pleomorphic Xanthoastrocytoma (APXA)</a><!-- start description -->
<div class="description"><p class="body">Pleomorphic xanthoastrocytoma (PXA) and anaplastic pleomorphic xanthoastrocytoma (APXA) tumors can be slow- or fast-growing tumors. They occur most often in young adulthood. Learn more about PXAs and APXAs.</p></div><!-- end description --></div><!-- end title & desc container -->
</li><li class="general-list-item general list-item">
<!-- cgvSnListItemGeneral -->
<!-- Image -->
<!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=6&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1120651&amp;sys_siteid=305&amp;sys_contentid=1120682&amp;sys_command=preview" sys_variantid="2297" sys_contentid="1120682">Primitive Neuro-Ectodermal Tumors (PNET)</a><!-- start description -->
<div class="description"><p class="body">Primitive Neuro-Ectodermal Tumors (PNET) are very rare, fast-growing tumors. PNETs is a group of tumors that form in the ectoderm, the outermost layer of cells of an embryo in early development. Learn more about PNETs.</p></div><!-- end description --></div><!-- end title & desc container -->
</li></ul></div></div>
<hr />
<p><em>We would like to acknowledge the following authors who have contributed to writing and reviewing content included on the 12 rare CNS tumor types highlighted on the NCI-CONNECT website: Terri Armstrong, PhD; Orwa Aboud, MD; Lisa Boris, MSN; Brittany Cordeiro; Maria Fletcher Ruiz; Mark Gilbert, MD; Kristin Odom; Carlos Romo, MD; Christine Siegel, MSN; Brett Theeler, MD; Elizabeth Vera, MS; Margarita Raygada, PhD, ScM, CGC. We would also like to acknowledge <a href="http://www.cbtrus.org/" target="_blank" rel="noopener noreferrer">Central Brain Tumor Registry of the United States (CBTRUS)</a>&nbsp;for&nbsp;epidemiologic data on the 12 rare CNS tumor types.</em></p>
</div>]]></body>
  </row>
  <row id="1140712" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>When you learn you have a rare brain or spine tumor, you may need help understanding what information is important to know to make care and treatment decisions. Our guiding questions can help prepare you for your appointments with your doctor or healthcare team so you can make informed decisions.</p>
<p>Use the questions below to guide you through your brain or spine tumor journey. You should use the questions that fit your situation and add your own questions. It can help to then take your list of questions and a loved one with you to your appointments.</p>
<ul>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122214" sys_contentid="1122214" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372772" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122214" sys_dependentvariantid="2297">Questions to Ask Your Neurosurgeon</a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=2&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122213" sys_contentid="1122213" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372773" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122213" sys_dependentvariantid="2297">Questions to Ask Your Doctor About Their Experience</a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122212" sys_contentid="1122212" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372774" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122212" sys_dependentvariantid="2297">Questions to Ask Your Doctor About Your Diagnosis </a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122218" sys_contentid="1122218" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372775" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122218" sys_dependentvariantid="2297">Questions to Ask Your Doctor About Your Treatment</a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122211" sys_contentid="1122211" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372776" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122211" sys_dependentvariantid="2297">Questions to Ask Your Doctor About Clinical Trials</a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=3&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122215" sys_contentid="1122215" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372777" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122215" sys_dependentvariantid="2297">Questions to Ask Your Doctor or Surgeon if You Have a Recurrence</a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122217" sys_contentid="1122217" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372778" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122217" sys_dependentvariantid="2297">Questions to Ask Your Doctor When Treatment Ends</a></li>
<li><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1122216" sys_contentid="1122216" inlinetype="rxhyperlink" sys_variantid="2297" sys_relationshipid="7372779" sys_siteid="305" rxinlineslot="103" sys_dependentid="1122216" sys_dependentvariantid="2297">Questions to Ask Your Doctor About Support</a></li>
</ul>
</div>]]></body>
  </row>
  <row id="1141709" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>NCI-CONNECT has a number of studies that are open for adult patients with rare central nervous system (CNS) cancers. Check back as we plan to add more.</p>
<h2>Online Study</h2>
<h3><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=3&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1121711" sys_dependentvariantid="2297" sys_dependentid="1121711" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_relationshipid="7326021" sys_variantid="2297" sys_contentid="1121711">Outcomes and Risk Project for Patients with Rare CNS Cancers</a></h3>
<p>The project aims to improve our understanding of outcomes and risk factors related to the occurrence of rare CNS cancers. Research shows that certain risk factors may increase a person&rsquo;s chances of developing cancer. Factors can include exposure to chemicals or other substances, and personal and family medical history. If you take part in this study, you will complete a web-based survey and submit a saliva sample that will be used for genetic testing.&nbsp;</p>
<div sys_dependentvariantid="2066" sys_dependentid="1123969" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="7326029">
<figure class="image-right-medium centered-set">
<div class="centered-element"><img src="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=1482&amp;sys_context=0&amp;sys_folderid=1120715&amp;sys_siteid=305&amp;sys_contentid=1123969&amp;sys_command=edit" alt="" /><!--Comment--> <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=1518&amp;sys_context=0&amp;sys_folderid=1120715&amp;sys_siteid=305&amp;sys_contentid=1123969&amp;sys_command=edit" target="_blank" class="article-image-enlarge no-resize" rel="noopener noreferrer" sys_variantid="1518" sys_contentid="1123969">Enlarge</a></div>
</figure>
</div>
<h2>Clinical Assessment</h2>
<h3><a href="https://www.cancer.gov/clinicaltrials/NCT02851706">Evaluation of the Natural History and Specimen Banking for Patients with CNS Cancers</a></h3>
<p>The study objective is to better understand brain and spinal cord tumors and uncover areas for further research. It also aims to connect patients with doctors who can help them manage their illness and give them new treatment options.&nbsp;</p>
<h2>Treatment Trials</h2>
<h3><a href="https://www.cancer.gov/clinicaltrials/NCT03173950">Immune Checkpoint Inhibitor Nivolumab for Patients with Rare CNS Cancers</a></h3>
<p>The clinical trial is investigating the immunotherapy drug nivolumab as an effective treatment for people with rare CNS tumors.&nbsp;</p>
<h3><a href="https://www.cancer.gov/clinicaltrials/NCI-2018-02730">Marizomib for Patients with Ependymoma</a></h3>
<p>This clinical trial is investigating the drug marizomib as an effective treatment for people with recurrent ependymoma.</p>
<h3><strong><a href="https://www.cancer.gov/clinicaltrials/NCI-2018-02512">Nivolumab for Patients with IDH-Mutant Gliomas</a></strong></h3>
<p>This clinical trial is investigating the immunotherapy drug nivolumab as an effective treatment for people with recurrent IDH-mutant gliomas with and without hypermutator phenotype.</p>
<h3><a href="https://www.cancer.gov/clinicaltrials/NCI-2018-03715" target="_blank" rel="noopener noreferrer">Sunitinib for Patients with Sarcomas of the CNS</a></h3>
<p>This clinical trial is investigating the drug sunitinib as an effective treatment for people with either a gliosarcoma or primary brain sarcoma.</p>
<h3><a href="https://www.cancer.gov/clinicaltrials/NCT01295944">Carboplatin and Bevacizumab for Patients with Ependymoma</a></h3>
<p>The clinical trial is investigating the combination of bevacizumab and carboplatin to help control recurrent ependymoma.</p>
</div>]]></body>
  </row>
  <row id="1144079" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>Hear advice and tips about care and treatment from patients and caregivers living with a rare central nervous system (CNS) tumor. Reading these stories can help guide and inspire you through your journey.</p>
<p>Have a <a href="/Rhythmyx/assembler/render?sys_contentid=1120626&amp;sys_revision=4&amp;sys_variantid=2317&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="2317" sys_dependentid="1120626" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7371358">rare CNS tumor</a> and want to share your story? E-mail us at <a href="mailto:nciconnect@mail.nih.gov">nciconnect@mail.nih.gov</a>.</p>
<p></p>
</div>]]></body>
  </row>
  <row id="7111878" langcode="en" long_title="Patients">
    <body><![CDATA[<div class="rxbodyfield">
<ul>
<li><a class="arrow-link" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1121711" sys_dependentvariantid="2297" sys_dependentid="1121711" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116923" sys_variantid="2297" sys_contentid="1121711">Join the Risk Study</a></li>
<li><a class="arrow-link" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2317&amp;sys_contentid=1120689" sys_dependentvariantid="2317" sys_dependentid="1120689" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116924" sys_variantid="2317" sys_contentid="1120689">Living with a Tumor</a></li>
<li><a class="arrow-link" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1120712" sys_dependentvariantid="1764" sys_dependentid="1120712" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116925" sys_variantid="1764" sys_contentid="1120712">Questions to Ask</a></li>
</ul>
</div>]]></body>
  </row>
  <row id="7116942" langcode="en" long_title="Practitioners">
    <body><![CDATA[<div class="rxbodyfield">
<ul>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1121709&amp;sys_revision=1&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="2297" sys_dependentid="1121709" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116934">Current Clinical Studies</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1120626&amp;sys_revision=1&amp;sys_variantid=2317&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="2317" sys_dependentid="1120626" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116935">Patient Information</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1121159&amp;sys_revision=1&amp;sys_variantid=2054&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="2054" sys_dependentid="1121159" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116936">NCI-CONNECT News</a></li>
</ul>
</div>]]></body>
  </row>
  <row id="7116943" langcode="en" long_title="Advocates">
    <body><![CDATA[<div class="rxbodyfield">
<ul>
<li><a class="arrow-link" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1121675" sys_dependentvariantid="2297" sys_dependentid="1121675" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116938" sys_variantid="2297" sys_contentid="1121675">Partner With Us</a></li>
<li><a class="arrow-link" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1124079" sys_dependentvariantid="2297" sys_dependentid="1124079" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7119421" sys_variantid="2297" sys_contentid="1124079">Patient and Advocate Stories</a></li>
<li><a class="arrow-link" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2317&amp;sys_contentid=1120626" sys_dependentvariantid="2317" sys_dependentid="1120626" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="7116940" sys_variantid="2317" sys_contentid="1120626">Share Resources</a></li>
</ul>
</div>]]></body>
  </row>
</rows>